NEW YORK, May 25, 2021 /PRNewswire/ — Illuminare Biotechnologies, a clinical-stage biotechnology company, announced that its novel nerve imaging agent, Illuminare-1, has been granted Fast Track ...
PHILADELPHIA--(BUSINESS WIRE)--Neuraptive Therapeutics, Inc. (Neuraptive), a clinical-stage biotechnology company dedicated to developing novel therapeutics and medical products for treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback